Krs Capital Management, LLC Pfizer Inc Transaction History

Krs Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $44,284 - $51,763	-1,380 Reduced 17.14%	6,671 $221,000
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $7,512 - $8,692	-208 Reduced 2.52%	8,051 $295,000
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $32,457 - $42,254	824 Added 11.08%	8,259 $336,000
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $13,360 - $17,440	320 Added 4.5%	7,435 $0
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $311,352 - $380,083	7,115 New	7,115 $311,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $167,811 - $207,938	-3,668 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $151,561 - $224,665	3,668 New	3,668 $216,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krs Capital Management, LLC with notifications on news.